|
(D) Medical management techniques such as denials, |
step therapy, or prior authorization in public and private |
health care coverage can impede access to the most |
effective contraceptive methods. |
(2) As used in this subsection (a): |
"Contraceptive services" includes consultations, |
examinations, procedures, and medical services related to the |
use of contraceptive methods (including natural family |
planning) to prevent an unintended pregnancy. |
"Medical necessity", for the purposes of this subsection |
(a), includes, but is not limited to, considerations such as |
severity of side effects, differences in permanence and |
reversibility of contraceptive, and ability to adhere to the |
appropriate use of the item or service, as determined by the |
attending provider. |
"Therapeutic equivalent version" means drugs, devices, or |
products that can be expected to have the same clinical effect |
and safety profile when administered to patients under the |
conditions specified in the labeling and satisfy the following |
general criteria: |
(i) they are approved as safe and effective; |
(ii) they are pharmaceutical equivalents in that they |
(A) contain identical amounts of the same active drug |
ingredient in the same dosage form and route of |
administration and (B) meet compendial or other applicable |
standards of strength, quality, purity, and identity; |
|
(iii) they are bioequivalent in that (A) they do not |
present a known or potential bioequivalence problem and |
they meet an acceptable in vitro standard or (B) if they do |
present such a known or potential problem, they are shown |
to meet an appropriate bioequivalence standard; |
(iv) they are adequately labeled; and |
(v) they are manufactured in compliance with Current |
Good Manufacturing Practice regulations. |
(3) An individual or group policy of accident and health |
insurance amended,
delivered, issued, or renewed in this State |
after the effective date of this amendatory Act of the 99th |
General Assembly shall provide coverage for all of the |
following services and contraceptive methods: |
(A) All contraceptive drugs, devices, and other |
products approved by the United States Food and Drug |
Administration. This includes all over-the-counter |
contraceptive drugs, devices, and products approved by the |
United States Food and Drug Administration, excluding male |
condoms. The following apply: |
(i) If the United States Food and Drug |
Administration has approved one or more therapeutic |
equivalent versions of a contraceptive drug, device, |
or product, a policy is not required to include all |
such therapeutic equivalent versions in its formulary, |
so long as at least one is included and covered without |
cost-sharing and in accordance with this Section. |
|
(ii) If an individual's attending provider |
recommends a particular service or item approved by the |
United States Food and Drug Administration based on a |
determination of medical necessity with respect to |
that individual, the plan or issuer must cover that |
service or item without cost sharing. The plan or |
issuer must defer to the determination of the attending |
provider. |
(iii) If a drug, device, or product is not covered, |
plans and issuers must have an easily accessible, |
transparent, and sufficiently expedient process that |
is not unduly burdensome on the individual or a |
provider or other individual acting as a patient's |
authorized representative to ensure coverage without |
cost sharing. |
(iv) This coverage must provide for the dispensing |
of 12 months' worth of contraception at one time. |
(B) Voluntary sterilization procedures. |
(C) Contraceptive services, patient education, and |
counseling on contraception. |
(D) Follow-up services related to the drugs, devices, |
products, and procedures covered under this Section, |
including, but not limited to, management of side effects, |
counseling for continued adherence, and device insertion |
and removal. |
(4) Except as otherwise provided in this subsection (a), a |
|
policy subject to this subsection (a) shall not impose a |
deductible, coinsurance, copayment, or any other cost-sharing |
requirement on the coverage provided. |
(5) Except as otherwise authorized under this subsection |
(a), a policy shall not impose any restrictions or delays on |
the coverage required under this subsection (a). |
(6) If, at any time, the Secretary of the United States |
Department of Health and Human Services, or its successor |
agency, promulgates rules or regulations to be published in the |
Federal Register or publishes a comment in the Federal Register |
or issues an opinion, guidance, or other action that would |
require the State, pursuant to any provision of the Patient |
Protection and Affordable Care Act (Public Law 111–148), |
including, but not limited to, 42 U.S.C. 18031(d)(3)(B) or any |
successor provision, to defray the cost of any coverage |
outlined in this subsection (a), then this subsection (a) is |
inoperative with respect to all coverage outlined in this |
subsection (a) other than that authorized under Section 1902 of |
the Social Security Act, 42 U.S.C. 1396a, and the State shall |
not assume any obligation for the cost of the coverage set |
forth in this subsection (a). |
(b) This subsection (b) shall become operative if and only |
if subsection (a) becomes inoperative. |
(a) An individual or group policy of accident and health |
insurance amended,
delivered, issued, or renewed in this State |
after the date this subsection (b) becomes operative effective |
|
date of this
amendatory Act of the 93rd General Assembly that |
provides coverage for
outpatient services and outpatient |
prescription drugs or devices must provide
coverage for the |
insured and any
dependent of the
insured covered by the policy |
for all outpatient contraceptive services and
all outpatient |
contraceptive drugs and devices approved by the Food and
Drug |
Administration. Coverage required under this Section may not |
impose any
deductible, coinsurance, waiting period, or other |
cost-sharing or limitation
that is greater than that required |
for any outpatient service or outpatient
prescription drug or |
device otherwise covered by the policy.
|
Nothing in this subsection (b) shall be construed to |
require an insurance
company to cover services related to |
permanent sterilization that requires a
surgical procedure. |
(b) As used in this subsection (b) Section , "outpatient |
contraceptive service" means
consultations, examinations, |
procedures, and medical services, provided on an
outpatient |
basis and related to the use of contraceptive methods |
(including
natural family planning) to prevent an unintended |
pregnancy.
|
(c) Nothing in this Section shall be construed to require |
an insurance
company to cover services related to an abortion |
as the term "abortion" is
defined in the Illinois Abortion Law |
of 1975.
|
(d) If a plan or issuer utilizes a network of providers, |
nothing in this Section shall be construed to require coverage |
|
or to prohibit the plan or issuer from imposing cost-sharing |
for items or services described in this Section that are |
provided or delivered by an out-of-network provider, unless the |
plan or issuer does not have in its network a provider who is |
able to or is willing to provide the applicable items or |
services. |
(d) Nothing in this Section shall be construed to require |
an insurance
company to cover services related to permanent |
sterilization that requires a
surgical procedure.
|
(Source: P.A. 95-331, eff. 8-21-07.)
|